 Survival
"Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.
| Descriptor ID |
D013534
|
| MeSH Number(s) |
I03.784
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Survival".
Below are MeSH descriptors whose meaning is more specific than "Survival".
This graph shows the total number of publications written about "Survival" by people in this website by year, and whether "Survival" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 3 | 4 | | 2010 | 1 | 1 | 2 | | 2013 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival" by people in Profiles.
-
Lheureux S, Cristea MC, Bruce JP, Garg S, Cabanero M, Mantia-Smaldone G, Olawaiye AB, Ellard SL, Weberpals JI, Wahner Hendrickson AE, Fleming GF, Welch S, Dhani NC, Stockley T, Rath P, Karakasis K, Jones GN, Jenkins S, Rodriguez-Canales J, Tracy M, Tan Q, Bowering V, Udagani S, Wang L, Kunos CA, Chen E, Pugh TJ, Oza AM. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021 01 23; 397(10271):281-292.
-
Chung SJ, Biernacka JM, Armasu SM, Anderson K, Frigerio R, Aasly JO, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga B, Jeon BS, Kim YJ, Kr?ger R, Lesage S, Markopoulou K, Mellick G, Morrison KE, Puschmann A, Tan EK, Crosiers D, Theuns J, Van Broeckhoven C, Wirdefeldt K, Wszolek ZK, Elbaz A, Maraganore DM. Alpha-synuclein repeat variants and survival in Parkinson's disease. Mov Disord. 2014 Jul; 29(8):1053-7.
-
Bodelon C, Polley MY, Kemp TJ, Pesatori AC, McShane LM, Caporaso NE, Hildesheim A, Pinto LA, Landi MT. Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer. Ann Oncol. 2013 Aug; 24(8):2073-9.
-
Asher SR, Curry P, Sharma D, Wang J, O'Keefe GE, Daniel-Johnson J, Vavilala MS. Survival advantage and PaO2 threshold in severe traumatic brain injury. J Neurosurg Anesthesiol. 2013 Apr; 25(2):168-73.
-
Vinchon-Petit S, Jarnet D, Michalak S, Lewis A, Benoit JP, Menei P. Local implantation of doxorubicin drug eluting beads in rat glioma. Int J Pharm. 2010 Dec 15; 402(1-2):184-9.
-
McPartland S, Hyman N, Blaszyk H, Osler T. The number of lymph nodes in colon cancer specimens: what do the numbers really mean? Colorectal Dis. 2010 Aug; 12(8):770-5.
-
Sacher A, Wollmann R, Kalokhe U, Munoz D, Guiot MC, Macdonald RL. Long-term survival of a patient with glioblastoma. Can J Neurol Sci. 2010 Mar; 37(2):289-92.
-
Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol. 2006 Jul 01; 24(19):3101-6.
-
Perkins JD. Intensive insulin therapy improves survival in critically ill patients: how does it work? Liver Transpl. 2006 Jun; 12(6):1014-5.
-
Dignam JJ. The ongoing search for the sources of the breast cancer survival disparity. J Clin Oncol. 2006 Mar 20; 24(9):1326-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|